Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating panobinostat in combination with carfilzomib and dexamethasone for relapsed and/or refractory multiple myeloma ha…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy [Phase 2]
Phase 2 trial evaluating carfilzomib in patients with multiple myeloma in first relapse or refractory to first-line therapy; the study was t…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetics of MFGR1877S in patients with relapsed or refractory t(4;14)-positive multiple …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating pomalidomide in combination with low-dose dexamethasone for Chinese patients with relapsed and refractory multiple …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of the investigational agent DFRF4539A in patients with relapsed or refractory multiple myeloma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating acupuncture to treat chemotherapy-induced peripheral neuropathy in patients with lymphoma or multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects [Phase 1]
A multicenter, open-label Phase 1b trial examines the combination of carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed mul…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma [Phase 2]
A Phase 2 trial evaluated Zevalin (ibritumomab tiuxetan) for patients with incomplete response to chemotherapy prior to autologous stem cell…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Fungemia in Hematologic Malignancies
This clinical trial update notes the completion of a study on fungemia (fungal bloodstream infections) in patients with hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluating the RAD regimen (lenalidomide, doxorubicin, dexamethasone) in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function [Phase 2]
Phase 2 pharmacokinetic study of lenalidomide (Revlimid) in patients with multiple myeloma and impaired renal function.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of Noscapine HCl (CB3304) in patients with relapsed or refractory multiple myeloma was terminated.
-
CLINICAL_TRIALS withdrawal · 2016-10-07Clinical Trial Update: Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1b/2 study evaluating Radium-223 dichloride in combination with Bortezomib and Dexamethasone for relapsed multiple myeloma has been …
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
This clinical trial update describes the S0120 study that collects blood and bone marrow samples from patients with monoclonal gammopathy of…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety and Pharmacokinetic Profile of CKD-581 [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetic profile of CKD-581 in patients with lymphoma and multiple myeloma. The study has…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Common Safety Follow-up Trial of Tecemotide (L-BLP25) [NA]
The common safety follow-up trial of Tecemotide (L-BLP25) was terminated, with results posted on 2016-10-06.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy [NA]
A European trial evaluating extended haemodialysis to remove free light chains in myeloma-associated cast nephropathy has completed.
-
CLINICAL_TRIALS research · 2016-10-04Clinical Trial Update: Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)
This completed clinical trial (MM-OO-16) investigates the prevalence of ocular disorders in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma [Phase 1]
Phase 1 multiple ascending dose trial update of a combination therapy in subjects with multiple myeloma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors [Phase 1]
A Phase 1 study of DKN-01 in multiple myeloma or advanced solid tumors has completed enrollment with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]
This clinical trial update reports the results of a Phase 1 study of daratumumab in Japanese participants with relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial of cyclophosphamide, carfilzomib, thalidomide, and dexamethasone for newly diagnosed active multiple myeloma has completed w…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma [Phase 2]
Phase II trial update of an intensive TOTAL THERAPY regimen for untreated or minimally treated multiple myeloma; results have been posted.